Antigenic relationship between the dermonecrotic toxins produced by Pasteurella multocida type D and type A

Area of Science:

• Veterinary Microbiology
• Immunology
• Bacterial Toxinology

Background:

• Atrophic rhinitis in pigs is often associated with Pasteurella multocida (P.m.) strains.
• Dermonecrotic toxins (DNT) produced by P.m. are key virulence factors.
• Understanding toxin cross-neutralization is crucial for vaccine development.

Purpose of the Study:

• To investigate the cross-neutralizing potential of antibodies against P.m. type D DNT.
• To evaluate the efficacy of type D DNT antiserum against type A P.m. DNT.

Main Methods:

• Preparation of crude dermonecrotic toxins (DNT) from P.m. type D and type A.
• Immunization of rabbits with P.m. type D DNT.
• In vitro and in vivo assays to assess serum neutralization (cytopathogenicity, mouse lethality, guinea pig dermonecrosis).

Main Results:

• Rabbit antiserum against P.m. type D DNT demonstrated significant neutralizing activity against P.m. type A DNT.
• Cross-neutralization was observed in both in vitro (cell culture) and in vivo (mouse and guinea pig) models.
• The degree of neutralization for homologous and heterologous toxins was comparable.

Conclusions:

• Antibodies generated against Pasteurella multocida type D dermonecrotic toxin can effectively neutralize type A dermonecrotic toxin.
• This cross-neutralization suggests potential for a broader protective immune response against different P.m. toxin types.
• Findings support the development of vaccines targeting conserved epitopes of P.m. dermonecrotic toxins.